Business Wire

CORRECTING and REPLACING Spirox Announces Positive Clinical Study Results for LATERA Implant in Patients with Nasal Valve Collapse, a Major Cause of Nasal Obstruction

MENLO PARK, Calif.--(BUSINESS WIRE)--In the media contact information, the email address should read: mbrokaw@spiroxmed.com (instead of mbrokaw@spirox.med.com). The corrected release reads: SPIROX ...
MedCity News

Startup wants to advance minimally invasive device to resolve nasal obstruction

Replacing a complicated surgery with a minimally invasive approach is a tried and true formula in medtech. Menlo Park, California-based startup Spirox is aiming to do that with its device to treat ...
Business Wire

Spirox Announces First US Cases with Minimally Invasive Device for Lateral Cartilage Support in Patients with Nasal Valve Collapse, a Major Cause of Nasal Obstruction

MENLO PARK, Calif.--(BUSINESS WIRE)--Spirox™, Inc., a company committed to transforming treatment of nasal obstruction, today announced the first US cases with the LATERA™ Absorbable Nasal Implant ...
NBC DFW

LATERA Nasal Implant Used to Improve Breathing

More than 20 million Americans suffer from nasal obstruction, which restricts breathing and impacts quality of life. Whether it’s caused by allergies, a deviated septum or swelling inside your nose, ...
WNDU

Under 30 minute procedure helps relieve breathing troubles

More than 20 million Americans suffer from nasal obstruction, which restricts breathing and impacts quality of life. Whether it’s caused by allergies, a deviated septum or swelling inside your nose, ...